Aro Biotherapeutics

0 followers


Unlocking the Potential of Genetic Medicines Based in Philadelphia, Aro Biotherapeutics is a biotechnology company pioneering the development of tissue-targeted genetic medicines with a platform based on a proprietary protein technology called Centyrins.

Industries

Employees

11-50

Links

Org chart

Susan Dillon
Co-Founder, President & CEO

Susan Dillon

Collapse
Karyn O’Neil
Co-Founder & Chief Scientific Officer
Mark Laurenzi
Chief Administrative Officer & VP, Legal
Sukumar Sakamuri
Chief Technology Officer
Zhanna Druzina
Sr. Director
Jeffrey Staiger
SVP, Finance & Business Development
Melissa Brookes
Vice President Clinical Operations

Board & advisors

Liz Mckee Anderson
Independent Director
Bruce Peacock
Independent Director
Christopher Mirabelli
Independent Director
Masad Damha
Scientific Advisor
Martin McMahon
Scientific Advisor
Ron Swanson
Scientific Advisor
Phillip S. Low
Scientific Advisor
Matthew Gentry
Scientific Advisor